Caldwell Trust CO Moderna, Inc. Transaction History

Caldwell Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Sep 24, 2025	SELL	$36.85 - $63.93 $5,048 - $8,758	-137 Closed	0 $0
Q1 2024 Sep 24, 2025	BUY	$85.37 - $115.44 $11,695 - $15,815	137 New	137 $14.6 Million
Q4 2023 Oct 01, 2025	SELL	$69.51 - $104.43 $18,906 - $28,404	-272 Reduced 66.5%	137 $13.6 Million
Q3 2023 Oct 01, 2025	BUY	$96.41 - $126.61 $6,266 - $8,229	65 Added 18.9%	409 $42.2 Million
Q2 2023 Oct 01, 2025	BUY	$118.5 - $160.53 $7,347 - $9,952	62 Added 21.99%	344 $41.8 Million

Q1 2023 Oct 01, 2025	BUY	$135.66 - $197.02 $38,256 - $55,559	282 New	282 $43.3 Million
Q4 2022 Oct 01, 2025	BUY	$118.38 - $210.04 $16,218 - $28,775	137 Added 210.77%	202 $36.3 Million
Q3 2022 Oct 01, 2025	BUY	$118.07 - $194.18 $7,674 - $12,621	65 New	65 $7.69 Million
Q1 2022 Oct 01, 2025	BUY	$126.46 - $235.05 $8,219 - $15,278	65 New	65 $11.2 Million
Q1 2021 Oct 02, 2025	BUY	$109.18 - $185.98 $7,096 - $12,088	65 New	65 $8.51 Million
Q4 2020 Oct 02, 2025	BUY	$65.74 - $169.86 $4,273 - $11,040	65 New	65 $6.79 Million

845

257M

39.6M

43.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

Stay updated on Caldwell Trust CO with notifications on news.